Literature DB >> 3549085

A case of recurrent lupus nephritis after renal transplantation.

K Kumano, T Sakai, S Mashimo, T Endo, K Koshiba, J S Elises, K Iitaka.   

Abstract

A case of recurrent lupus nephritis in an 18-year-old girl with a renal transplant is described. Serological titer of ANA and Anti-DNA were low prior to renal transplantation following pulse therapy with methylpredonisolone and high dose oral predonisolone. A living related transplantation was performed after 6 months of hemodialysis. Maintenance immunosuppressive therapy consisted of predonisolone, mizoribine and cyclophosphamide. Graft function remained stable for one and half years after transplantation. Clinical recurrence was heralded by the development of proteinuria. If the serologic activities had been analyzed, the increase in ANA and Anti-DNA titers a few months before the onset of proteinuria might have predicted a possible histopathological recurrence. Fortunately, however, despite the histological and clinical recurrence of systemic lupus erythematosus, her renal allograft has continued to function fairly well.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3549085

Source DB:  PubMed          Journal:  Clin Nephrol        ISSN: 0301-0430            Impact factor:   0.975


  4 in total

Review 1.  Kidney transplantation in patients with systemic lupus erythematosus.

Authors:  Sophia Lionaki; Chrysanthi Skalioti; John N Boletis
Journal:  World J Transplant       Date:  2014-09-24

2.  Steroid-sparing effect of mizoribine in long-term nephrotic syndrome of children.

Authors:  Y Igarashi; Y Moro; Y Kondo; C N Inoue
Journal:  Pediatr Nephrol       Date:  1994-06       Impact factor: 3.714

3.  Lupus nephritis in a pediatric renal transplant recipient.

Authors:  L Fox; P G Zager; A M Harford; K S Tung; S M Smith
Journal:  Pediatr Nephrol       Date:  1992-09       Impact factor: 3.714

Review 4.  Recurrent primary disease and de novo nephritis following renal transplantation.

Authors:  J S Cameron
Journal:  Pediatr Nephrol       Date:  1991-07       Impact factor: 3.714

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.